Trump Attributes Hand Bruises to Aspirin Use, Dismisses Speculation

President Donald Trump has addressed the ongoing speculation surrounding the bruises on his hands, attributing them to his long-term use of high-dose aspirin. In an extensive interview with The Wall Street Journal published on January 1, 2026, Trump took the opportunity to counter claims regarding his health as he enters his second term at age 79.

The interview comes after months of public scrutiny regarding the visible marks on Trump’s hands, which have raised concerns about his overall well-being. He revealed that he has been taking a daily dose of 325 milligrams of aspirin—significantly higher than the commonly recommended low dose of 81 milligrams. Trump explained that he believes “aspirin is good for thinning out the blood” and he is “a little superstitious” about changing his long-standing routine.

Trump’s admission has sparked renewed debate about transparency in presidential health. Medical experts caution that while low-dose aspirin is often prescribed for cardiovascular prevention, higher doses can lead to an increased risk of bruising, particularly in older adults. This aligns with clinical perspectives, even as Trump frames his choice as personal prerogative.

In the interview, Trump provided context for his bruising, sharing an anecdote about sustaining a minor cut from a high-five with his attorney general nominee. This candid moment served to humanize the discussion around his health, highlighting the vulnerability that comes with age. He also noted that he occasionally uses makeup or bandages to manage the appearance of bruises, a practice that reflects his awareness of public perception.

Trump’s health has been a contentious topic, intensified by previous reports of swelling in his legs, which led to a diagnosis of chronic venous insufficiency. This condition, common in older adults, affects the veins’ ability to return blood from the legs to the heart. Furthermore, Trump’s clarification regarding a diagnostic imaging procedure previously referred to as an MRI revealed it was actually a CT scan performed for preventive cardiovascular evaluation.

Despite the scrutiny, Trump maintains that he is in “perfect” health, a claim he has reiterated since late 2025. He defended his mental acuity and energy levels, stating that he begins work early and keeps a demanding schedule. Trump attributes any perceived moments of fatigue in public to simple blinking or resting his eyes, rather than any underlying health issue.

The response to Trump’s revelations has been mixed. Supporters applauded his candor and downplayed the significance of the bruises in light of his busy agenda. Critics, on the other hand, argue that the situation raises important questions about the transparency of presidential health and the potential implications of unaddressed medical concerns.

Independent physicians have weighed in on the matter, noting that while age and aspirin use can contribute to easy bruising, the recurrence and visibility of such symptoms necessitate comprehensive disclosure regarding medications and health conditions. Many analysts believe that the episode illustrates a broader issue concerning the management of presidential health and the public’s right to know about their leader’s fitness.

As the debate continues, Trump’s approach to addressing the speculation—characterized by personal anecdotes and a defiant stance—reflects his ongoing strategy to connect with his base. The issue of health transparency is likely to remain a focal point in political discourse throughout 2026, as public interest in the well-being of leaders persists.